Vincerx Pharma, Inc. (VINC) Tops Q4 EPS by 14c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q4 EPS of ($0.23), $0.14 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Rubrik (RBRK) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY27 EPS Guidance
• Warsh, Nvidia And oil In focus - what’s moving markets